Hims Drops Fat-Loss Pill After FDA Warning

Online telehealth company Hims & Hers on Saturday reversed course on its launch of a $49 compounded version of Novo Nordisk’s Wegovy weight-loss pill after the U.S. Food and Drug Administration said it would take action against it. “Since launching the compounded semaglutide pill on our platform, we’ve had constructive conversations with stakeholders across the ...